Lyndsey Davies is the founder of Amber Therapeutics. Amber Therapeutics has raised $100M, latest Series A $100M (2024). Biotech · London, UK.
Lyndsey Davies is the founder of Amber Therapeutics. Amber Therapeutics operates in Biotech and is based in London, UK. Amber Therapeutics has raised $100M, latest Series A $100M (2024). Backers on record include Alexander Snow, Oxford Science Enterprises.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in London — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library